On February 28, 2024 Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, reported that members of management will participate in upcoming investor conferences in March (Press release, Elevation Oncology, FEB 28, 2024, View Source [SID1234640622]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 44th Annual Health Care Conference. Fireside chat on Wednesday, March 6, 2024 at 10:30 AM ET in Boston, MA.
Leerink Global Biopharma Conference. Management will participate in investor meetings on Tuesday, March 12, 2024 in Miami, FL.
A live webcast and replay of the fireside chat at the TD Cowen 44th Annual Health Care Conference will be available on the Events page of the Company’s Investor Relations website at View Source